Healthcare MoneyTree™ report: Q2 2018

Start adding items to your reading lists:
Save this item to:
This item has been saved to your reading list.

PwC and CB Insights' Healthcare MoneyTree™ report brings you a quarterly publication based on US venture capital funding for healthcare related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers, and Global healthcare trends.

For full analysis of Q2’18 activity across all sectors, refer to the PwC/CB Insights MoneyTree™ Report.

Healthcare deals increased in Q2’18

Deal numbers have increased by 21% from the prior quarter, with 191 deals closing in Q2’18.

Highlights for this quarters' report include, but are not limited to:
  • The share of early stage deals increased from 20% in Q1’18 to 32% in Q2’18 and early and expansion stage deals continue to make up more than half of the dollars raised this quarter.
  • Seed stage companies received larger funding than usual as the median deal size for seed stage deals increased to $5.4M, an eight-quarter high, in Q2’18.
  • Biotechnology related industries raised more than $4 billion for the second consecutive quarter.
  • New England remained above Silicon Valley in dollars invested in Q2’18, with $1,725M raised this quarter through 41 deals.


Contact us

Greg Vlahos
Partner, US Pharmaceuticals and Life Sciences , PwC US
Tel: +1 (408) 817 5029

Laura Robinette
US Pharmaceutical and Life Sciences Assurance Leader, PwC US
Tel: +1 (919) 791 4100

Tim Weld
Health Services Assurance Leader, PwC US
Tel: +1 (646) 471 2477

Follow us